Unknown

Dataset Information

0

Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis.


ABSTRACT: Scavenger receptor SR-BI significantly contributes to HDL cholesterol metabolism and atherogenesis in mice. However, the role of SR-BI may not be as pronounced in humans due to cholesteryl ester transfer protein (CETP) activity. To address the impact of CETP expression on the adverse effects associated with SR-BI deficiency, we cross-bred our SR-BI conditional knock-out mouse model with CETP transgenic mice. CETP almost completely restored the abnormal HDL-C distribution in SR-BI-deficient mice. However, it did not normalize the elevated plasma free to total cholesterol ratio characteristic of hepatic SR-BI deficiency. Red blood cell and platelet count abnormalities observed in mice liver deficient for SR-BI were partially restored by CETP, but the elevated erythrocyte cholesterol to phospholipid ratio remained unchanged. Complete deletion of SR-BI was associated with diminished adrenal cholesterol stores, whereas hepatic SR-BI deficiency resulted in a significant increase in adrenal gland cholesterol content. In both mouse models, CETP had no impact on adrenal cholesterol metabolism. In diet-induced atherosclerosis studies, hepatic SR-BI deficiency accelerated aortic lipid lesion formation in both CETP-expressing (4-fold) and non-CETP-expressing (8-fold) mice when compared with controls. Impaired macrophage to feces reverse cholesterol transport in mice deficient for SR-BI in liver, which was not corrected by CETP, most likely contributed by such an increase in atherosclerosis susceptibility. Finally, comparison of the atherosclerosis burden in SR-BI liver-deficient and fully deficient mice demonstrated that SR-BI exerted an atheroprotective activity in extra-hepatic tissues whether CETP was present or not. These findings support the contention that the SR-BI pathway contributes in unique ways to cholesterol metabolism and atherosclerosis susceptibility even in the presence of CETP.

SUBMITTER: El Bouhassani M 

PROVIDER: S-EPMC3089565 | biostudies-literature | 2011 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Cholesteryl ester transfer protein expression partially attenuates the adverse effects of SR-BI receptor deficiency on cholesterol metabolism and atherosclerosis.

El Bouhassani Majda M   Gilibert Sophie S   Moreau Martine M   Saint-Charles Flora F   Tréguier Morgan M   Poti Francesco F   Chapman M John MJ   Le Goff Wilfried W   Lesnik Philippe P   Huby Thierry T  

The Journal of biological chemistry 20110320 19


Scavenger receptor SR-BI significantly contributes to HDL cholesterol metabolism and atherogenesis in mice. However, the role of SR-BI may not be as pronounced in humans due to cholesteryl ester transfer protein (CETP) activity. To address the impact of CETP expression on the adverse effects associated with SR-BI deficiency, we cross-bred our SR-BI conditional knock-out mouse model with CETP transgenic mice. CETP almost completely restored the abnormal HDL-C distribution in SR-BI-deficient mice.  ...[more]

Similar Datasets

| S-EPMC3220294 | biostudies-literature
| S-EPMC5805397 | biostudies-literature
| S-EPMC9464954 | biostudies-literature
| S-EPMC2823947 | biostudies-literature
| S-EPMC5928430 | biostudies-literature
| S-EPMC3924318 | biostudies-literature
| S-EPMC2975716 | biostudies-literature
| S-EPMC4479333 | biostudies-literature
| S-EPMC1137510 | biostudies-other
| S-EPMC2784759 | biostudies-literature